BAR HARBOR, Maine — Over the past year, billions of dollars and countless hours of research have gone into developing a vaccine for COVID-19.
Not every virus, illness, or disease gets that kind of attention. Rare diseases receive relatively little attention and investment from pharmaceutical companies.
By United States standards, a “rare and orphan disease” is one that affects fewer than 200,000 people. Read more